Logo for Axcella Health Inc

Axcella Health Investor Relations Material

Latest events

Logo for Axcella Health

Q2 2023

3 Aug, 2023
Logo for Axcella Health

Q1 2023

4 May, 2023
Access the full event backlog
Slides, Transcripts, and Reports from over 8,000 public companies
Axcella Health Inc is a clinical stage biotechnology company in the United States. The company is focused on development of endogenous metabolic modulator compositions for complex diseases and enhanced health. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence; and AXA1125 that is in Phase 2b clinical trial for treating non-alcoholic steatohepatitis, as well as in Phase 2a clinical trial for Long COVID therapy for patients. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts."